Clinical Trial Update: Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab in combination with cytarabine and mitoxantrone for hematologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYTARABINE (CYTARABINE)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED